Nadav Ahituv
Nadav Ahituv is a Professor in the Department of Bioengineering and Therapeutic Sciences and the Director for the Institute for Human Genetics at the University of California, San Francisco (USCF).[1][2][3] He also leads the Ahituv Lab at UCSF.[1][4]
Early Life and Education
He received his PhD in human genetics from Tel-Aviv University, where he worked on hereditary hearing loss.[3][2]
Research
The Ahituv Lab, under the leadership of Nadav Ahituv, investigates gene regulatory elements and their relationship to human diversity and disease.[4] The lab is focused on identifying gene regulatory elements and linking nucleotide variation within them to various phenotypes, including morphological differences between species, drug response, and human disease.[5] The lab has co-developed massively parallel reporter assays (MPRAs) that allow for high-throughput functional characterization of gene regulatory elements.[6] It also pioneered cis-regulation therapy (CRT) for genetic diseases that are caused due to low gene dosage and adipose manipulation transplantation (AMT) that engineers fat cells and implants them for therapeutic benefits.[7][8]
Awards and Honors
- ASCPT Leon I. Goldberg young investigator award from The American Society for Clinical Pharmacology and Therapeutics in 2014.[9][1]
References
- ↑ 1.0 1.1 1.2 1.3 "Nadav Ahituv | UCSF Profiles". profiles.ucsf.edu. Retrieved 2024-03-05.
- ↑ 2.0 2.1 2.2 "Nadav Ahituv". Simons Institute for the Theory of Computing. Retrieved 2024-03-05.
- ↑ 3.0 3.1 "Speaker Template". PMWC Precision Medicine World Conference. Retrieved 2024-03-05.
- ↑ 4.0 4.1 "About · Ahituv Lab". Ahituv Lab. Retrieved 2024-03-05.
- ↑ "Nadav Ahituv, PhD". UCSF Institute for Human Genetics. Retrieved 2024-03-05.
- ↑ Kreimer, Anat; Ashuach, Tal; Inoue, Fumitaka; Khodaverdian, Alex; Deng, Chengyu; Yosef, Nir; Ahituv, Nadav (2022-03-21). "Massively parallel reporter perturbation assays uncover temporal regulatory architecture during neural differentiation". Nature Communications. 13 (1): 1504. Bibcode:2022NatCo..13.1504K. doi:10.1038/s41467-022-28659-0. ISSN 2041-1723. PMC 8938438 Check
|pmc=value (help). PMID 35315433 Check|pmid=value (help). - ↑ Matharu, Navneet; Ahituv, Nadav (2020-11-01). "Modulating gene regulation to treat genetic disorders". Nature Reviews. Drug Discovery. 19 (11): 757–775. doi:10.1038/s41573-020-0083-7. ISSN 1474-1784. PMID 33020616 Check
|pmid=value (help). Unknown parameter|s2cid=ignored (help) - ↑ Matharu, Navneet; Ahituv, Nadav (2020-11-01). "Modulating gene regulation to treat genetic disorders". Nature Reviews Drug Discovery. 19 (11): 757–775. doi:10.1038/s41573-020-0083-7. ISSN 1474-1784. PMID 33020616 Check
|pmid=value (help). Unknown parameter|s2cid=ignored (help) - ↑ "Nadav Ahituv, PhD | Department of Medicine". medicine.ucsf.edu. Retrieved 2024-03-05.
This article "Nadav Ahituv" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Nadav Ahituv. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
